Spota | Accession Numberb | Protein Description | Mr(KDa)/ p I | Score | Coverage (%)d | Normalized spot volume (vol%)e | p | Ratio (infected/mock-infected) | Protein function | Other viruses found inf | |
---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  |  |  | Mock-infected | IBV-infected |  |  |  |  |
Cytoskeletal proteins | |||||||||||
2 | gi|515694 | Tropomyosin beta chain [Gallus gallus] | 28.5/4.65 | 123 | 31 | 0.2134 ± 0.0092 | 0.0524 ± 0.0162 | < 0.001 | 0.25 | Actin binding | HBV, HCV, WSSV |
3 | gi|45382323 | Tropomyosin 1 alpha [Gallus gallus] | 32.9/4.73 | 307 | 57 | 0.1907 ± 0.0219 | 0.0474 ± 0.0188 | 0.001 | 0.25 | Actin binding | PRRSV, RSV, HPV8, VHSV, CVB3 |
Calcium ion-binding proteins | |||||||||||
1 | gi|45382533 | annexin A2 [Gallus gallus] | 38.7/6.92 | 389 | 67 | 0.0388 ± 0.0177 | 0.2153 ± 0.0838 | 0.023 | 5.55 | Phospholipase inhibitor activity. Calcium ion binding | CSFV, PRRSV, HBV, HIV, DHBV, WNV |
12 | gi|45382533 | annexin A2 [Gallus gallus] | 38.6/6.92 | 505 | 69 | 0.5186 ± 0.1260 | 0.1549 ± 0.0474 | 0.009 | 0.3 | Phospholipase inhibitor activity. Calcium ion binding |  |
4 | gi|71895873 | annexin 5 [Gallus gallus] | 36.2/5.6 | 402 | 71 | 0.4276 ± 0.0516 | 0.1898 ± 0.0334 | 0.003 | 0.44 | Calcium ion binding. Calcium-dependent phospholipid binding | PRRSV, DV, DHBV, HBV, VHSV |
17 | gi|50982399 | annexin A6 [Gallus gallus] | 75.2/5.57 | 441 | 49 | 0.4317 ± 0.0389 | 0.1653 ± 0.0107 | < 0.001 | 0.38 | Calcium ion binding. Calcium-dependent phospholipid binding |  |
19 | gi|45382893 | calbindin 1, 28 kDa [Gallus gallus] | 30.4/4.72 | 212 | 60 | N/A | 0.1485 ± 0.0614 | 0.014 | N/A | Calcium ion binding. Vitamin D binding |  |
20-1 | gi|45382893 | calbindin 1, 28 kDa [Gallus gallus] | 30.2/4.72 | 285 | 50 | N/A | 0.1527 ± 0.0545 | 0.008 | N/A | Calcium ion binding. Vitamin D binding |  |
Carbohydrate and lipid metabolic proteins | |||||||||||
5 | gi|46048696 | carbonic anhydrase II [Gallus gallus] | 29.4/6.56 | 354 | 75 | 0.2622 ± 0.0554 | 0.4806 ± 0.0850 | 0.020 | 1.83 | Morphogenesis of an epithelium. One-carbon metabolic process |  |
8 | gi|71895267 | carbonyl reductase 1 [Gallus gallus] | 30.5/8.5 | 357 | 82 | 0.1847 ± 0.0160 | 0.0909 ± 0.0220 | 0.004 | 0.49 | Catalytic activity. Oxidoreductase activity | VHSV |
10 | gi|45383766 | L-lactate dehydrogenase B [Gallus gallus] | 36.3/7.07 | 306 | 40 | 0.3102 ± 0.0260 | 0.6368 ± 0.1152 | 0.009 | 2.05 | Glycolysis. Oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | PRRSV, HBV, HIV, IBDV, REOV |
11 | gi|118090053 | similar to L-3-hydroxyacyl-Coenzyme A dehydrogenase, short chain [Gallus gallus] | 34.4/8.68 | 135 | 39 | 0.0814 ± 0.0048 | 0.2186 ± 0.0820 | 0.044 | 2.69 | Catalytic activity. Oxidoreductase activity. Fatty acid metabolic process |  |
14 | gi|118093509 | PREDICTED: similar to cytosolic NADP-dependent isocitrate dehydrogenase [Gallus gallus] | 46.6/8.02 | 412 | 47 | 0.2077 ± 0.0198 | 0.0942 ± 0.0092 | 0.001 | 0.45 | Oxidoreductase activity | PRRSV, PCV2, HBV, RSV |
15 | gi|46048768 | enolase 1 [Gallus gallus] | 47.3/6.17 | 387 | 57 | 0.5718 ± 0.1537 | 1.2489 ± 0.0439 | 0.002 | 2.18 | Glycolysis | PRRSV, PCV2, WSSV, HSV-1, RSV, DHBV, HIV, IBDV, HBV, VHSV, WNV, SARS-CoV |
18 | gi|110591367 | Chain A, The Structure Of Chicken Mitochondrial Pepck | 67.3/6.55 | 441 | 49 | 0.0866 ± 0.0138 | 0.1704 ± 0.0253 | 0.007 | 1.97 | Gluconeogenesis | HBV, SARS-CoV |
Amino acid metabolic proteins | |||||||||||
6 | gi|2981970 | glutathione S-transferases 2 [Gallus gallus] | 25.8/7.0 | 437 | 68 | 0.1877 ± 0.0201 | 0.4192 ± 0.0767 | 0.007 | 2.23 | Amino acid metabolic process | HBV |
13 | gi|118094764 | PREDICTED: similar to cystathionase [Gallus gallus] | 43.9/6.86 | 399 | 35 | 0.1704 ± 0.0390 | 0.3164 ± 0.0547 | 0.02 | 1.86 | Cysteine biosynthetic process |  |
Antioxidative stress proteins | |||||||||||
7 | gi|50751518 | PREDICTED: similar to peroxiredoxin-1 [Gallus gallus] | 22.3/8.24 | 252 | 42 | 0.5474 ± 0.0371 | 0.1253 ± 0.0600 | < 0.001 | 0.23 | Response to oxidative stress. Removal of superoxide radicals. Regulation of stress-activated MAPK cascade | CSFV, PRRSV, RSV, SARS-CoV, HBV, IAV |
Protein processing | |||||||||||
16 | gi|57530409 | CNDP dipeptidase 2 [Gallus gallus] | 53.1/5.71 | 403 | 52 | 0.1743 ± 0.0319 | 0.3196 ± 0.0759 | 0.038 | 1.83 | Proteolysis |  |
9 | gi|45382969 | sulfotransferase family, cytosolic, 1C, member 3 [Gallus gallus] | 36.2/6.68 | 245 | 47 | 0.1481 ± 0.0412 | 0.2923 ± 0.0578 | 0.024 | 1.97 | Sulfotransferase activity. Detoxicating |  |
Immune response proteins | |||||||||||
20-2 | gi|54606655 | MHC class I antigen [Gallus gallus] | 37.6/6.09 | 385c | 71 | N/A | 0.1527 ± 0.0545 | 0.008 | N/A | Immune response. Antigen processing and presentation | BVDV |